BRPI0307620B8 - moléculas de polinucleotídeo codificando variantes de avec, métodos para produzir uma cepa recombinante de streptomyces avermitilis, bem como as referidas células recombinantes e composição de avermectinas - Google Patents
moléculas de polinucleotídeo codificando variantes de avec, métodos para produzir uma cepa recombinante de streptomyces avermitilis, bem como as referidas células recombinantes e composição de avermectinasInfo
- Publication number
- BRPI0307620B8 BRPI0307620B8 BRPI0307620A BR0307620A BRPI0307620B8 BR PI0307620 B8 BRPI0307620 B8 BR PI0307620B8 BR PI0307620 A BRPI0307620 A BR PI0307620A BR 0307620 A BR0307620 A BR 0307620A BR PI0307620 B8 BRPI0307620 B8 BR PI0307620B8
- Authority
- BR
- Brazil
- Prior art keywords
- recombinant
- polynucleotide molecules
- variants
- producing
- methods
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
- C12P17/181—Heterocyclic compounds containing oxygen atoms as the only ring heteroatoms in the condensed system, e.g. Salinomycin, Septamycin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/44—Preparation of O-glycosides, e.g. glucosides
- C12P19/60—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
- C12P19/62—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin
- C12P19/623—Avermectin; Milbemycin; Ivermectin; C-076
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Veterinary Medicine (AREA)
- Physics & Mathematics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Virology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Detergent Compositions (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US35622202P | 2002-02-12 | 2002-02-12 | |
| PCT/IB2003/000348 WO2003068955A2 (en) | 2002-02-12 | 2003-01-31 | Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| BR0307620A BR0307620A (pt) | 2004-12-07 |
| BRPI0307620B1 BRPI0307620B1 (pt) | 2015-08-11 |
| BRPI0307620B8 true BRPI0307620B8 (pt) | 2016-09-13 |
Family
ID=27734621
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0307620A BRPI0307620B8 (pt) | 2002-02-12 | 2003-01-31 | moléculas de polinucleotídeo codificando variantes de avec, métodos para produzir uma cepa recombinante de streptomyces avermitilis, bem como as referidas células recombinantes e composição de avermectinas |
Country Status (25)
| Country | Link |
|---|---|
| US (2) | US7388085B2 (https=) |
| EP (2) | EP1476539B1 (https=) |
| JP (1) | JP2005517406A (https=) |
| KR (1) | KR100718378B1 (https=) |
| CN (2) | CN1630712B (https=) |
| AR (1) | AR038405A1 (https=) |
| AT (2) | ATE426659T1 (https=) |
| AU (1) | AU2003245052B2 (https=) |
| BR (1) | BRPI0307620B8 (https=) |
| CA (1) | CA2475214C (https=) |
| CY (2) | CY1110454T1 (https=) |
| DE (1) | DE60326824D1 (https=) |
| DK (2) | DK1476539T3 (https=) |
| ES (2) | ES2373629T3 (https=) |
| IL (3) | IL162866A0 (https=) |
| ME (1) | ME00472B (https=) |
| MX (1) | MXPA04007777A (https=) |
| PL (1) | PL211693B1 (https=) |
| PT (2) | PT1476539E (https=) |
| RS (1) | RS50813B (https=) |
| RU (1) | RU2293117C2 (https=) |
| SI (2) | SI2050815T1 (https=) |
| TW (1) | TWI341330B (https=) |
| WO (1) | WO2003068955A2 (https=) |
| ZA (1) | ZA200405345B (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1476539T3 (da) | 2002-02-12 | 2009-05-11 | Pfizer Prod Inc | Streptomyces avermitilis gen dirigerende forholdet af B2:B1 avermectiner |
| CN102241750B (zh) * | 2010-05-14 | 2014-05-28 | 中国科学院微生物研究所 | 一种生产阿维菌素的基因工程方法及其专用菌株 |
| CN102093997B (zh) * | 2010-12-01 | 2013-03-13 | 中国科学院上海有机化学研究所 | 一种改造除虫链霉菌产生多拉菌素的方法 |
| CN109576196B (zh) * | 2019-01-25 | 2022-01-04 | 北大方正集团有限公司 | 一种生产多拉菌素的发酵培养基及多拉菌素的生产方法 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE434277B (sv) | 1976-04-19 | 1984-07-16 | Merck & Co Inc | Sett att framstella nya antihelmintiskt verkande foreningar genom odling av streptomyces avermitilis |
| US4429042A (en) | 1978-09-08 | 1984-01-31 | Merck & Co., Inc. | Strain of Streptomyces for producing antiparasitic compounds |
| IN167980B (https=) | 1987-01-23 | 1991-01-19 | Pfizer | |
| US5252474A (en) | 1989-03-31 | 1993-10-12 | Merck & Co., Inc. | Cloning genes from Streptomyces avermitilis for avermectin biosynthesis and the methods for their use |
| JP2761296B2 (ja) * | 1993-10-05 | 1998-06-04 | フアイザー・インコーポレイテツド | ドラメクチンの製造方法および駆虫性中間体 |
| US6117679A (en) | 1994-02-17 | 2000-09-12 | Maxygen, Inc. | Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
| US5605793A (en) | 1994-02-17 | 1997-02-25 | Affymax Technologies N.V. | Methods for in vitro recombination |
| US5837458A (en) | 1994-02-17 | 1998-11-17 | Maxygen, Inc. | Methods and compositions for cellular and metabolic engineering |
| US6248579B1 (en) | 1998-02-13 | 2001-06-19 | Pfizer Inc | Streptomyces avermitilis gene directing the ratio of B2:B1 avermectins |
| EA003905B1 (ru) * | 1998-02-13 | 2003-10-30 | Пфайзер Продактс Инк. | Ген streptomyces avermitilis, контролирующий соотношение авермектинов b2:b1 |
| RU2156301C2 (ru) * | 1998-06-09 | 2000-09-20 | Мосин Владимир Александрович | Штамм актиномицета streptomyces avermitilis ссм 4697 - продуцент авермектинов |
| US6197591B1 (en) | 1998-09-14 | 2001-03-06 | Pfizer Inc. | Streptomyces avermitilis regulatory genes for increased avermectin production |
| CA2380872C (en) * | 1999-08-12 | 2007-11-27 | Yan Chen | Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins |
| MXPA02001565A (es) | 1999-08-13 | 2005-07-14 | Vertex Pharma | Inhibidores de cinasas c-jun n-terminal (jnk) y de otras cinasas proteicas. |
| DK1476539T3 (da) * | 2002-02-12 | 2009-05-11 | Pfizer Prod Inc | Streptomyces avermitilis gen dirigerende forholdet af B2:B1 avermectiner |
-
2003
- 2003-01-31 DK DK03739390T patent/DK1476539T3/da active
- 2003-01-31 RS YUP-700/04A patent/RS50813B/sr unknown
- 2003-01-31 SI SI200332087T patent/SI2050815T1/sl unknown
- 2003-01-31 AT AT03739390T patent/ATE426659T1/de active
- 2003-01-31 KR KR1020047012437A patent/KR100718378B1/ko not_active Expired - Lifetime
- 2003-01-31 SI SI200331553T patent/SI1476539T1/sl unknown
- 2003-01-31 RU RU2004124521/13A patent/RU2293117C2/ru active
- 2003-01-31 DE DE60326824T patent/DE60326824D1/de not_active Expired - Lifetime
- 2003-01-31 ME MEP-2008-730A patent/ME00472B/me unknown
- 2003-01-31 CA CA2475214A patent/CA2475214C/en not_active Expired - Lifetime
- 2003-01-31 WO PCT/IB2003/000348 patent/WO2003068955A2/en not_active Ceased
- 2003-01-31 CN CN038037416A patent/CN1630712B/zh not_active Expired - Lifetime
- 2003-01-31 BR BRPI0307620A patent/BRPI0307620B8/pt not_active IP Right Cessation
- 2003-01-31 JP JP2003568070A patent/JP2005517406A/ja active Pending
- 2003-01-31 AU AU2003245052A patent/AU2003245052B2/en not_active Expired
- 2003-01-31 MX MXPA04007777A patent/MXPA04007777A/es active IP Right Grant
- 2003-01-31 ES ES09150098T patent/ES2373629T3/es not_active Expired - Lifetime
- 2003-01-31 CN CN2011102082591A patent/CN102392028B/zh not_active Expired - Lifetime
- 2003-01-31 ES ES03739390T patent/ES2321827T3/es not_active Expired - Lifetime
- 2003-01-31 DK DK09150098.3T patent/DK2050815T3/da active
- 2003-01-31 EP EP03739390A patent/EP1476539B1/en not_active Expired - Lifetime
- 2003-01-31 PT PT03739390T patent/PT1476539E/pt unknown
- 2003-01-31 AT AT09150098T patent/ATE530645T1/de active
- 2003-01-31 IL IL16286603A patent/IL162866A0/xx unknown
- 2003-01-31 PT PT09150098T patent/PT2050815E/pt unknown
- 2003-01-31 EP EP09150098A patent/EP2050815B1/en not_active Expired - Lifetime
- 2003-01-31 PL PL371320A patent/PL211693B1/pl unknown
- 2003-02-10 AR ARP030100408A patent/AR038405A1/es active IP Right Grant
- 2003-02-10 US US10/361,376 patent/US7388085B2/en not_active Expired - Lifetime
- 2003-02-10 TW TW092102676A patent/TWI341330B/zh not_active IP Right Cessation
-
2004
- 2004-07-05 ZA ZA200405345A patent/ZA200405345B/xx unknown
- 2004-07-05 IL IL162866A patent/IL162866A/en active IP Right Grant
-
2008
- 2008-04-23 US US12/107,949 patent/US8008078B2/en not_active Expired - Fee Related
- 2008-06-22 IL IL192371A patent/IL192371A/en active IP Right Grant
-
2009
- 2009-04-27 CY CY20091100467T patent/CY1110454T1/el unknown
-
2011
- 2011-12-02 CY CY20111101193T patent/CY1112491T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0312276A (pt) | Mimeticorpos ch1-removidos miméticos de epo de mamìfero, composições, métodos e usos | |
| BR0112979A (pt) | Método de produzir domìnios de proteìna funcional | |
| ES2318119T3 (es) | Procedimiento y composiciones para alterar el perfil del efecto edulcorante de la sucralosa. | |
| WO2005058945A3 (de) | Genvarianten die für proteine aus dem stoffwechselweg von feinchemikalien kodieren | |
| BR0212886A (pt) | Célula bacteriana, método para a produção de um polipeptìdeo heterólogo, método para a prevenção de clivagem, métodos para a clivagem e métodos para a produção de um polipeptìdeo clivado | |
| BRPI0307620B8 (pt) | moléculas de polinucleotídeo codificando variantes de avec, métodos para produzir uma cepa recombinante de streptomyces avermitilis, bem como as referidas células recombinantes e composição de avermectinas | |
| BRPI0406477A (pt) | Composição, agente de tratamento de óleo, e, métodos de produção de uma composição e de tratamento de óleo | |
| BRPI0608220A2 (pt) | artigo dentário | |
| UY26287A1 (es) | Gen de streptomyces avermitilis que que dirige la relación de avermectinas b2:b1 | |
| BR112021025474A2 (pt) | Mutantes estabilizados de lactonase de quorum quenching e uso seu em tratamento de patógenos | |
| CO5070698A1 (es) | Gen de streptomyces avermitilis que dirige la relacion de avermectinas b2:b1 | |
| BR0013119A (pt) | Gene de streptomyces avermitilis que regula a proporção de avermectinas b2:bl | |
| Motoki et al. | Isozyme-specific modules on human aldolase A molecule. Isozyme group-specific sequences 1 and 4 are required for showing characteristics as aldolase A. | |
| BR9911597A (pt) | Genes que codificam épsilon licopeno ciclase e método para a produção de épsilon caroteno bicìclico | |
| BRPI0519330A2 (pt) | Ácido nuclÉico isolado; vetor; cÉlula hospedeira; mÉtodo para expressar uma proteÍna; polipeptÍdeo isolado; cromoproteÍna isolada; oligonucleotÍdeo; mÉtodo para identificar um Ácido nuclÉico que codifica uma apoproteÍna de um enediina de nove membros contendo cromoproteÍna; cultura biologicamente pura de actinomadura sp. 21g792 (nrrl 30778); mÉtodo para preparar uma cromoproteÍna; mÉtodo para preparar uma cromoproteÍna modificada; mÉtodo para inibir a progressço de uma doenÇa neoplÁsica em um mamÍfero; composiÇço farmacÊutica; e composto | |
| FR2792651B1 (fr) | Sequence genomique et polypeptides de pyrococcus abyssi, leurs fragments et leurs utilisations | |
| ECSP941123A (es) | Genes que codifican el complejo cetoacido deshidrogenasa de cadena ramificada de streptomyces avermitilis | |
| EP1945270A4 (en) | COMPOSITIONS AND METHODS FOR INHIBITING THE EXPRESSION OF FACTOR V SUFFER MUTATION GENES | |
| BRPI0409192A (pt) | microorganismo contendo genes tdcbc/pcka inativados e método de produção de l-treonina usando o mesmo | |
| WO2007079753A3 (en) | Mutant deoxyadenosine kinase enzymes and their use | |
| WO2002086067A3 (en) | Mycobacterial sulfation pathway proteins and methods of use thereof | |
| BRPI0314543B8 (pt) | células hospedeiras, dna recombinante, utilização dos mesmos, processos de produção de um polipeptídeo implicado na biossíntese das espiramicinas, de produção de macrolídeos e de produção de espiramicina(s), e micro-organismo transgênico mutante produtor de macrolídeo | |
| BR0100470A (pt) | Regulação e manipulação do teor de sacarose em cana-de-açúcar | |
| BRPI0406168A (pt) | processo para produção da enzima antileucêmica asparaginase a partir da clonagem do gene asp3 de saccharomyces cerevisiae em uma levedura metilotrófica | |
| WO2004001071A3 (en) | Genetic predisposition analysis and treatment |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B25A | Requested transfer of rights approved |
Owner name: PAH USA 15 LLC (US) |
|
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B25D | Requested change of name of applicant approved |
Owner name: ZOETIS P LLC (US) |
|
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 11/08/2015, OBSERVADAS AS CONDICOES LEGAIS. |
|
| B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: REFERENTE AO DESPACHO 16.1 PUBLICADO NA RPI 2327 DE 11.08.2015, QUANTO A FORMATACAO DO DOCUMENTO |
|
| B25A | Requested transfer of rights approved | ||
| B25G | Requested change of headquarter approved | ||
| B21A | Patent or certificate of addition expired [chapter 21.1 patent gazette] |
Free format text: PATENTE EXTINTA EM 11/08/2025 |